\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ underwent\\ excision\\ of\\ the\\ lesion\\ and\\ evacuation\\ of\\ the\\ hematoma\\.\ \(0\)\
\-\ ct\\ followed\\ by\\ mr\\ \\(fig\\.\\ 1a\\-f\\)\\ demonstrated\\ a\\ nodular\\ lesion\\ in\\ the\\ right\\ frontal\\ subcortical\\ region\\,\\ surrounded\\ by\\ an\\ area\\ of\\ hematoma\\ in\\ late\\ subacute\\ stage\\ and\\ by\\ hyperintense\\ perilesional\\ oedema\\ on\\ t1wi\\.\ \(0\)\
\-\ cerebral\\ cavernous\\ malformation\\.\ \(0\)\
\-\ the\\ differential\\ diagnosis\\ was\\ between\\ cerebral\\ cavernous\\ malformation\\ \\(ccm\\,\\ cavernoma\\)\\ and\\ haemorrhagic\\ metastasis\\.\ \(0\)\
\-\ a\\ 33\\-year\\-old\\ man\\ presented\\ with\\ headache\\,\\ left\\ hemiparesis\\,\\ hemihypoesthesia\\ and\\ partial\\ seizures\\ of\\ the\\ left\\ arm\\ for\\ a\\ week\\.\\ no\\ personal\\ or\\ familial\\ significant\\ history\\ was\\ present\\.\ \(0\)\
\-\ companion\\ cases\\:\\ http\\:\\/\\/goo\\.gl\\/tx2xvc\ \(0\)\
\-\ ccm\\ is\\ considered\\ the\\ third\\ most\\ prevalent\\ vascular\\ malformation\\ of\\ the\\ brain\\,\\ after\\ development\\ venous\\ anomaly\\ \\(dva\\)\\ and\\ capillary\\ telangiectasia\\,\\ affecting\\ 0\\.5\\%\\ to\\ 0\\.7\\%\\ of\\ the\\ population\\.\\ \ \(0\)\
\-\ histologically\\,\\ ccm\\ is\\ formed\\ by\\ dilated\\ capillaries\\ without\\ elastic\\ and\\ muscular\\ tunics\\,\\ which\\ makes\\ it\\ susceptible\\ to\\ multiple\\ bleedings\\ and\\ explains\\ the\\ mr\\ appearance\\ of\\ haemorrhage\\ in\\ different\\ phases\\ of\\ evolution\\.\\ it\\ is\\ limited\\ at\\ the\\ periphery\\ by\\ a\\ pseudocapsule\\ of\\ gliotic\\ brain\\ infiltrated\\ by\\ hemosiderin\\,\\ resulting\\ in\\ a\\ hypointense\\ peripheral\\ ring\\ on\\ t2wi\\.\\ when\\ associated\\ with\\ dva\\,\\ the\\ main\\ hypothesis\\ of\\ the\\ pathogenesis\\ of\\ ccm\\ sustains\\ that\\ the\\ first\\ step\\ is\\ a\\ hyperpressure\\ in\\ a\\ branch\\ of\\ the\\ dva\\.\\ this\\ produces\\ high\\ pressure\\ in\\ the\\ capillary\\ bed\\ and\\ chronic\\ microbleeds\\ which\\ stimulate\\ fibroblastic\\ and\\ endothelial\\ proliferation\\ with\\ the\\ final\\ result\\ of\\ ccm\\.\\ as\\ well\\,\\ cavernoma\\ can\\ also\\ occur\\ as\\ a\\ result\\ of\\ radiation\\ injury\\,\\ through\\ a\\ similar\\ mechanism\\ of\\ proliferation\\ and\\ dilatation\\ of\\ the\\ vascular\\ endothelium\\ and\\ capillaries\\.\ \(0\)\
\-\ ccm\\ can\\ affect\\ all\\ cerebral\\ regions\\,\\ albeit\\ it\\ is\\ more\\ frequent\\ in\\ the\\ subcortical\\ areas\\ of\\ frontal\\ and\\ temporal\\ lobes\\.\\ when\\ situated\\ in\\ the\\ posterior\\ fossa\\,\\ it\\ has\\ a\\ tendency\\ to\\ involve\\ the\\ pons\\ and\\ the\\ cerebellar\\ hemispheres\\.\\ one\\ third\\ to\\ one\\ half\\ of\\ ccm\\ are\\ clinically\\ silent\\.\\ the\\ symptomatology\\ is\\ usually\\ associated\\ with\\ haemorrhagic\\ events\\.\ \(0\)\
\-\ there\\ are\\ different\\ forms\\ to\\ classify\\ ccm\\,\\ the\\ most\\ used\\ being\\ the\\ sporadic\\ versus\\ familial\\ forms\\ and\\ the\\ zabramski\\ classification\\.\\ the\\ sporadic\\ form\\ usually\\ presents\\ as\\ a\\ unique\\ lesion\\ and\\ it\\ has\\ strong\\ association\\ with\\ dva\\ which\\ is\\ commonly\\ adjacent\\ to\\ the\\ ccm\\ and\\ involved\\ in\\ its\\ pathogenesis\\.\\ on\\ the\\ other\\ hand\\,\\ the\\ familial\\ form\\ is\\ represented\\ by\\ multiple\\ lesions\\,\\ has\\ no\\ association\\ with\\ dva\\ and\\ it\\ does\\ have\\ higher\\ risk\\ of\\ complications\\.\\ the\\ zabramski\\ classification\\ is\\ based\\ on\\ the\\ haemorrhagic\\ aspect\\ of\\ ccm\\ and\\ includes\\:\\ type\\ 1\\,\\ subacute\\ haemorrhage\\ \\(hyperintense\\ on\\ t1wi\\,\\ hyper\\-\\ or\\ hypointense\\ on\\ t2wi\\)\\,\\ type\\ 2\\,\\ \\"popcorn\\ ball\\"\\ appearance\\ \\(mixed\\-signal\\ intensity\\ on\\ t1\\-\\ and\\ t2wi\\,\\ hypointense\\ ring\\ on\\ t2wi\\)\\,\\ type\\ 3\\,\\ chronic\\ haemorrhage\\ \\(iso\\-\\ or\\ hypointense\\ on\\ t1\\-\\ and\\ t2wi\\,\\ also\\ hypointense\\ ring\\)\\ and\\ type\\ 4\\,\\ patchy\\ microbleeds\\ \\(punctate\\ hyperintense\\ lesions\\ on\\ t2\\*\\,\\ \\"black\\ dots\\"\\)\\.\ \(0\)\
\-\ on\\ ct\\,\\ up\\ to\\ half\\ of\\ ccm\\ cannot\\ be\\ identified\\,\\ the\\ others\\ being\\ slightly\\ hyperdense\\,\\ well\\ defined\\,\\ sometimes\\ with\\ calcifications\\.\\ the\\ mr\\ appearance\\ is\\ heterogeneous\\,\\ consequence\\ of\\ different\\ stages\\ of\\ haemorrhage\\.\\ a\\ hypointense\\ peripheral\\ ring\\ frequently\\ appears\\ on\\ t2wi\\,\\ explained\\ by\\ the\\ presence\\ of\\ hemosiderin\\.\\ on\\ t2\\*\\-gradient\\ recalled\\ echo\\ \\(gre\\)\\ and\\ susceptibility\\-weighted\\ imaging\\ \\(swi\\)\\ it\\ manifests\\ high\\ susceptibility\\ magnetic\\ properties\\,\\ presenting\\ pronounced\\ hypointense\\ signal\\.\\ when\\ a\\ ccm\\ is\\ studied\\,\\ the\\ administration\\ of\\ contrast\\ is\\ recommended\\ in\\ order\\ to\\ search\\ for\\ a\\ dva\\.\\ the\\ reasons\\ are\\ the\\ high\\ association\\ between\\ the\\ two\\ malformations\\ and\\,\\ more\\ importantly\\,\\ when\\ dealing\\ with\\ a\\ surgical\\ ccm\\,\\ being\\ aware\\ of\\ the\\ presence\\ of\\ a\\ dva\\ is\\ essential\\ in\\ order\\ to\\ avoid\\ a\\ venous\\ infarct\\ which\\ would\\ result\\ from\\ cutting\\ the\\ dva\\.\\ ccm\\ usually\\ does\\ not\\ enhance\\.\\ sometimes\\ it\\ is\\ difficult\\ to\\ differentiate\\ a\\ complicated\\ cavernoma\\ from\\ a\\ haemorrhagic\\ neoplasm\\.\\ noteworthily\\,\\ it\\ was\\ showed\\ that\\ hyperintense\\ perilesional\\ signal\\ on\\ t1wi\\ can\\ be\\ seen\\ in\\ more\\ than\\ half\\ of\\ the\\ patients\\ with\\ ccm\\,\\ this\\ being\\ of\\ particular\\ value\\ when\\ the\\ diagnosis\\ is\\ uncertain\\ and\\ a\\ therapeutic\\ decision\\ is\\ required\\ \\[ajnr\\ 2008\\;29\\:494\\â\\€\\“500\\]\\.\ \(0\)\
\-\ references\ \(24\)\
\-\ yun\\ tj\\,\\ na\\ dg\\,\\ kwon\\ bj\\,\\ rho\\ hg\\,\\ park\\ s\\-h\\,\\ suh\\ y\\-l\\,\\ et\\ al\\.\\ a\\ t1\\ hyperintense\\ perilesional\\ signal\\ aids\\ in\\ the\\ differentiation\\ of\\ a\\ cavernous\\ angioma\\ from\\ other\\ hemorrhagic\\ masses\\.\\ ajnr\\ am\\ j\\ neuroradiol\\ 2008\\;29\\:494\\â\\€\\“500\\.\ \(0\)\
\-\ petersen\\ t\\ a\\,\\ morrison\\ l\\ a\\,\\ schrader\\ rm\\,\\ hart\\ bl\\.\\ familial\\ versus\\ sporadic\\ cavernous\\ malformations\\:\\ differences\\ in\\ developmental\\ venous\\ anomaly\\ association\\ and\\ lesion\\ phenotype\\.\\ ajnr\\ am\\ j\\ neuroradiol\\ 2010\\;31\\:377\\â\\€\\“82\\.\ \(0\)\
\-\ zabramski\\ jm\\,\\ wascher\\ tm\\,\\ spetzler\\ rf\\,\\ johnson\\ b\\,\\ golfinos\\ j\\,\\ drayer\\ bp\\,\\ et\\ al\\.\\ the\\ natural\\ history\\ of\\ familial\\ cavernous\\ malformations\\:\\ results\\ of\\ an\\ ongoing\\ study\\.\\ j\\ neurosurg\\ 1994\\;80\\:422\\â\\€\\“32\\.\ \(0\)\
\-\ cort\\Ã\\©s\\ vela\\ jj\\,\\ concepci\\Ã\\³n\\ aramend\\Ã\\­a\\ l\\,\\ ballenilla\\ marco\\ f\\,\\ gallego\\ le\\Ã\\³n\\ ji\\,\\ gonz\\Ã\\¡lez\\-sp\\Ã\\­nola\\ san\\ gil\\ j\\.\\ cerebral\\ cavernous\\ malformations\\:\\ spectrum\\ of\\ neuroradiological\\ findings\\.\\ radiologia\\ 2012\\;54\\:401\\â\\€\\“9\\.\ \(0\)\
\-\ al\\-shahi\\ salman\\ r\\,\\ hall\\ jm\\,\\ horne\\ ma\\,\\ moultrie\\ f\\,\\ josephson\\ cb\\,\\ bhattacharya\\ jj\\,\\ et\\ al\\.\\ untreated\\ clinical\\ course\\ of\\ cerebral\\ cavernous\\ malformations\\:\\ a\\ prospective\\,\\ population\\-based\\ cohort\\ study\\.\\ lancet\\ neurol\\ 2012\\;11\\:217\\â\\€\\“24\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ccm\\:\\ 0\\.5299259446137936\ \(0\)\
\-\ dva\\:\\ 0\\.23044545227476423\ \(0\)\
\-\ the\\:\\ 0\\.20758485553377462\ \(0\)\
\-\ of\\:\\ 0\\.15382300800917062\ \(0\)\
\-\ t2wi\\:\\ 0\\.14838307207676996\ \(0\)\
\-\ haemorrhagic\\:\\ 0\\.14788664587532727\ \(0\)\
\-\ hypointense\\:\\ 0\\.1424115502681493\ \(0\)\
\-\ cavernous\\:\\ 0\\.14037620912731902\ \(0\)\
\-\ haemorrhage\\:\\ 0\\.13007686383900985\ \(0\)\
\-\ familial\\:\\ 0\\.12573273899492102\ \(0\)\
\-\ and\\:\\ 0\\.11942934969257471\ \(0\)\
\-\ malformations\\:\\ 0\\.1166235836358472\ \(0\)\
\-\ zabramski\\:\\ 0\\.11091498440649544\ \(0\)\
\-\ it\\:\\ 0\\.10650675686997915\ \(0\)\
\-\ is\\:\\ 0\\.10129893559788232\ \(0\)\
\-\ on\\:\\ 0\\.09775096232734326\ \(0\)\
\-\ cavernoma\\:\\ 0\\.09568342662068081\ \(0\)\
\-\ hyperintense\\:\\ 0\\.09194874284060356\ \(0\)\
\-\ perilesional\\:\\ 0\\.08913010683575602\ \(0\)\
\-\ ajnr\\:\\ 0\\.08489526459157294\ \(0\)\
\-\ association\\:\\ 0\\.08322057837503984\ \(0\)\
\-\ in\\:\\ 0\\.08051617539104697\ \(0\)\
\-\ cerebral\\:\\ 0\\.08008386379872989\ \(0\)\
\-\ sporadic\\:\\ 0\\.07882834453367812\ \(0\)\
\-\ by\\:\\ 0\\.0785399596991834\ \(0\)\
\-\ ring\\:\\ 0\\.07789514565308413\ \(0\)\
\-\ t1wi\\:\\ 0\\.07577277030851796\ \(0\)\
\-\ al\\:\\ 0\\.0734764945411121\ \(0\)\
\-\ when\\:\\ 0\\.06982483632909799\ \(0\)\
\-\ microbleeds\\:\\ 0\\.06832496224199607\ \(0\)\
\-\ half\\:\\ 0\\.0653271202718508\ \(0\)\
\-\ being\\:\\ 0\\.06443977784844808\ \(0\)\
\-\ different\\:\\ 0\\.06347335044226853\ \(0\)\
\-\ jj\\:\\ 0\\.06270660154632851\ \(0\)\
\-\ type\\:\\ 0\\.06203534216543773\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.06175190159701376\ \(0\)\
\-\ susceptibility\\:\\ 0\\.06089789339118221\ \(0\)\
\-\ capillaries\\:\\ 0\\.06012534899782979\ \(0\)\
\-\ jm\\:\\ 0\\.058170590384786315\ \(0\)\
\-\ to\\:\\ 0\\.057796025769887543\ \(0\)\
\-\ pathogenesis\\:\\ 0\\.05527953269551465\ \(0\)\
\-\ et\\:\\ 0\\.054330404730219266\ \(0\)\
\-\ malformation\\:\\ 0\\.053491563756076374\ \(0\)\
\-\ signal\\:\\ 0\\.052421089957022104\ \(0\)\
\-\ result\\:\\ 0\\.05192219710198603\ \(0\)\
\-\ hemosiderin\\:\\ 0\\.051727221804432316\ \(0\)\
\-\ 2012\\:\\ 0\\.05051518020567864\ \(0\)\
\-\ subcortical\\:\\ 0\\.04986638754608141\ \(0\)\
\-\ proliferation\\:\\ 0\\.049661171999847084\ \(0\)\
\-\ venous\\:\\ 0\\.04951695818861807\ \(0\)\
\-\ capillary\\:\\ 0\\.04852832023933583\ \(0\)\
\-\ forms\\:\\ 0\\.04818334983250222\ \(0\)\
\-\ classification\\:\\ 0\\.047534557172904994\ \(0\)\
\-\ 2008\\:\\ 0\\.047228649883187486\ \(0\)\
\-\ mr\\:\\ 0\\.04487634842030027\ \(0\)\
\-\ lesion\\:\\ 0\\.04433426908453046\ \(0\)\
\-\ population\\:\\ 0\\.043744412658920734\ \(0\)\
\-\ usually\\:\\ 0\\.04366203058307195\ \(0\)\
\-\ am\\:\\ 0\\.04364733867096003\ \(0\)\
\-\ subacute\\:\\ 0\\.04327026691082709\ \(0\)\
\-\ sometimes\\:\\ 0\\.04327026691082709\ \(0\)\
\-\ t1\\:\\ 0\\.043212982341230805\ \(0\)\
\-\ order\\:\\ 0\\.04273563925280476\ \(0\)\
\-\ anomaly\\:\\ 0\\.04231556696151235\ \(0\)\
\-\ which\\:\\ 0\\.042049015125211184\ \(0\)\
\-\ appearance\\:\\ 0\\.04181190917712406\ \(0\)\
\-\ versus\\:\\ 0\\.04089251244248708\ \(0\)\
\-\ with\\:\\ 0\\.040742183969947623\ \(0\)\
\-\ form\\:\\ 0\\.04042539499388693\ \(0\)\
\-\ high\\:\\ 0\\.039417278738096646\ \(0\)\
\-\ more\\:\\ 0\\.03808373906428463\ \(0\)\
\-\ hemihypoesthesia\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ tunics\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ bleedings\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ sustains\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ hyperpressure\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ noteworthily\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ rho\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ suh\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ schrader\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ wascher\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ golfinos\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ vela\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ concepci\\Ã\\³n\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ aramend\\Ã\\­a\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ ballenilla\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ gallego\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ le\\Ã\\³n\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ neuroradiological\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ radiologia\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ salman\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ horne\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ moultrie\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ josephson\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ bhattacharya\\:\\ 0\\.03697166146883182\ \(0\)\
\-\ can\\:\\ 0\\.03639571396635735\ \(0\)\
\-\ oedema\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ gliotic\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ swi\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ kwon\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ hart\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ drayer\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ marco\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ gil\\:\\ 0\\.035328396307586246\ \(0\)\
\-\ third\\:\\ 0\\.03520574981250373\ \(0\)\
\-\ dots\\:\\ 0\\.03416248112099803\ \(0\)\
\-\ dealing\\:\\ 0\\.03416248112099803\ \(0\)\
\-\ ji\\:\\ 0\\.03416248112099803\ \(0\)\
\-\ cb\\:\\ 0\\.03416248112099803\ \(0\)\
\-\ based\\:\\ 0\\.03349296681375027\ \(0\)\
\-\ endothelium\\:\\ 0\\.033258127043424894\ \(0\)\
\-\ classify\\:\\ 0\\.033258127043424894\ \(0\)\
\-\ spetzler\\:\\ 0\\.033258127043424894\ \(0\)\
\-\ presence\\:\\ 0\\.03322185187108465\ \(0\)\
\-\ peripheral\\:\\ 0\\.03306343156228333\ \(0\)\
\-\ tj\\:\\ 0\\.03251921595975246\ \(0\)\
\-\ cohort\\:\\ 0\\.03251921595975246\ \(0\)\
\-\ hematoma\\:\\ 0\\.03236251279948149\ \(0\)\
\-\ does\\:\\ 0\\.03196475658232985\ \(0\)\
\-\ explains\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ pseudocapsule\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ fibroblastic\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ cutting\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ phenotype\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ johnson\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ hall\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ lancet\\:\\ 0\\.03189447554022694\ \(0\)\
\-\ has\\:\\ 0\\.03167969755789478\ \(0\)\
\-\ albeit\\:\\ 0\\.031353300773164255\ \(0\)\
\-\ studied\\:\\ 0\\.031353300773164255\ \(0\)\
\-\ park\\:\\ 0\\.031353300773164255\ \(0\)\
\-\ situated\\:\\ 0\\.03087595079850688\ \(0\)\
\-\ neurol\\:\\ 0\\.03087595079850688\ \(0\)\
\-\ study\\:\\ 0\\.030836869955887213\ \(0\)\
\-\ vascular\\:\\ 0\\.030525078396500337\ \(0\)\
\-\ elastic\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ stimulate\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ represented\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ properties\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ morrison\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ rm\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ bl\\:\\ 0\\.030448946695591107\ \(0\)\
\-\ infiltrated\\:\\ 0\\.030062674498914897\ \(0\)\
\-\ hypothesis\\:\\ 0\\.030062674498914897\ \(0\)\
\-\ importantly\\:\\ 0\\.030062674498914897\ \(0\)\
\-\ differences\\:\\ 0\\.030062674498914897\ \(0\)\
\-\ between\\:\\ 0\\.030042681808383348\ \(0\)\
\-\ frontal\\:\\ 0\\.029759488599124587\ \(0\)\
\-\ prevalent\\:\\ 0\\.029710035611918678\ \(0\)\
\-\ tendency\\:\\ 0\\.029710035611918678\ \(0\)\
\-\ silent\\:\\ 0\\.029710035611918678\ \(0\)\
\-\ consequence\\:\\ 0\\.029710035611918678\ \(0\)\
\-\ dg\\:\\ 0\\.029710035611918678\ \(0\)\
\-\ personal\\:\\ 0\\.029385639282120065\ \(0\)\
\-\ recalled\\:\\ 0\\.029385639282120065\ \(0\)\
\-\ susceptible\\:\\ 0\\.029085295192393158\ \(0\)\
\-\ endothelial\\:\\ 0\\.029085295192393158\ \(0\)\
\-\ bj\\:\\ 0\\.029085295192393158\ \(0\)\
\-\ brain\\:\\ 0\\.02882413833938462\ \(0\)\
\-\ manifests\\:\\ 0\\.02880568153434553\ \(0\)\
\-\ neurosurg\\:\\ 0\\.02880568153434553\ \(0\)\
\-\ san\\:\\ 0\\.02880568153434553\ \(0\)\
\-\ aware\\:\\ 0\\.02854412042533047\ \(0\)\
\-\ histologically\\:\\ 0\\.028298421530524313\ \(0\)\
\-\ as\\:\\ 0\\.027862676628266046\ \(0\)\
\-\ gre\\:\\ 0\\.027847647326877455\ \(0\)\
\-\ step\\:\\ 0\\.027639766347757326\ \(0\)\
\-\ hg\\:\\ 0\\.027639766347757326\ \(0\)\
\-\ rf\\:\\ 0\\.027639766347757326\ \(0\)\
\-\ ma\\:\\ 0\\.027639766347757326\ \(0\)\
\-\ from\\:\\ 0\\.027545173794595354\ \(0\)\
\-\ chronic\\:\\ 0\\.02744507086661576\ \(0\)\
\-\ events\\:\\ 0\\.027253494151081113\ \(0\)\
\-\ popcorn\\:\\ 0\\.027253494151081113\ \(0\)\
\-\ explained\\:\\ 0\\.027253494151081113\ \(0\)\
\-\ telangiectasia\\:\\ 0\\.0270733404675017\ \(0\)\
\-\ evolution\\:\\ 0\\.0270733404675017\ \(0\)\
\-\ tm\\:\\ 0\\.0270733404675017\ \(0\)\
\-\ natural\\:\\ 0\\.026900855264084894\ \(0\)\
\-\ untreated\\:\\ 0\\.026735412270184177\ \(0\)\
\-\ prospective\\:\\ 0\\.026735412270184177\ \(0\)\
\-\ t2\\:\\ 0\\.026601528228556475\ \(0\)\
\-\ phases\\:\\ 0\\.02657645893428628\ \(0\)\
\-\ lesions\\:\\ 0\\.026554539220941285\ \(0\)\
\-\ one\\:\\ 0\\.026472958276633436\ \(0\)\
\-\ are\\:\\ 0\\.026317362659308192\ \(0\)\
\-\ symptomatology\\:\\ 0\\.026276114844559377\ \(0\)\
\-\ decision\\:\\ 0\\.026276114844559377\ \(0\)\
\-\ 1994\\:\\ 0\\.026276114844559377\ \(0\)\
\-\ evacuation\\:\\ 0\\.026133897075003222\ \(0\)\
\-\ unique\\:\\ 0\\.025996501186511745\ \(0\)\
\-\ pronounced\\:\\ 0\\.025863610902216158\ \(0\)\
\-\ essential\\:\\ 0\\.025863610902216158\ \(0\)\
\-\ uncertain\\:\\ 0\\.025734940077496687\ \(0\)\
\-\ ongoing\\:\\ 0\\.025734940077496687\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.025489241182690532\ \(0\)\
\-\ fig\\:\\ 0\\.025371760766986228\ \(0\)\
\-\ produces\\:\\ 0\\.025371760766986228\ \(0\)\
\-\ formed\\:\\ 0\\.0251465477989842\ \(0\)\
\-\ aids\\:\\ 0\\.0251465477989842\ \(0\)\
\-\ companion\\:\\ 0\\.024933193773040704\ \(0\)\
\-\ stages\\:\\ 0\\.024730512012794994\ \(0\)\
\-\ 2010\\:\\ 0\\.024632849683313796\ \(0\)\
\-\ ball\\:\\ 0\\.02453748550561337\ \(0\)\
\-\ reasons\\:\\ 0\\.02453748550561337\ \(0\)\
\-\ associated\\:\\ 0\\.024370463232747067\ \(0\)\
\-\ muscular\\:\\ 0\\.024353236025266168\ \(0\)\
\-\ others\\:\\ 0\\.024353236025266168\ \(0\)\
\-\ differentiate\\:\\ 0\\.024353236025266168\ \(0\)\
\-\ angioma\\:\\ 0\\.024264160119667914\ \(0\)\
\-\ was\\:\\ 0\\.0241711745437628\ \(0\)\
\-\ or\\:\\ 0\\.024127639448498567\ \(0\)\
\-\ strong\\:\\ 0\\.02409167491625111\ \(0\)\
\-\ punctate\\:\\ 0\\.02409167491625111\ \(0\)\
\-\ search\\:\\ 0\\.02409167491625111\ \(0\)\
\-\ most\\:\\ 0\\.024063230635454073\ \(0\)\
\-\ other\\:\\ 0\\.02401171193798956\ \(0\)\
\-\ bed\\:\\ 0\\.02400810926378828\ \(0\)\
\-\ avoid\\:\\ 0\\.02400810926378828\ \(0\)\
\-\ diagnosis\\:\\ 0\\.023969028421168603\ \(0\)\
\-\ affect\\:\\ 0\\.023926231922350393\ \(0\)\
\-\ magnetic\\:\\ 0\\.02384597602144495\ \(0\)\
\-\ surrounded\\:\\ 0\\.023767278586452497\ \(0\)\
\-\ pons\\:\\ 0\\.023767278586452497\ \(0\)\
\-\ black\\:\\ 0\\.023690080241751517\ \(0\)\
\-\ value\\:\\ 0\\.023539959725674183\ \(0\)\
\-\ spectrum\\:\\ 0\\.023466934496725593\ \(0\)\
\-\ therapeutic\\:\\ 0\\.023395201817798097\ \(0\)\
\-\ periphery\\:\\ 0\\.02332471672716944\ \(0\)\
\-\ affecting\\:\\ 0\\.02325543656907732\ \(0\)\
\-\ makes\\:\\ 0\\.023187320838677965\ \(0\)\
\-\ branch\\:\\ 0\\.022680060834856748\ \(0\)\
\-\ final\\:\\ 0\\.022680060834856748\ \(0\)\
\-\ multiple\\:\\ 0\\.022615612957569493\ \(0\)\
\-\ particular\\:\\ 0\\.022562580419152444\ \(0\)\
\-\ patchy\\:\\ 0\\.022505093064405637\ \(0\)\
\-\ hemispheres\\:\\ 0\\.022448409755005536\ \(0\)\
\-\ differentiation\\:\\ 0\\.022448409755005536\ \(0\)\
\-\ well\\:\\ 0\\.02238827238007805\ \(0\)\
\-\ complicated\\:\\ 0\\.021921331664961213\ \(0\)\
\-\ na\\:\\ 0\\.021921331664961213\ \(0\)\
\-\ late\\:\\ 0\\.021823669335480016\ \(0\)\
\-\ mechanism\\:\\ 0\\.0217757067572836\ \(0\)\
\-\ also\\:\\ 0\\.0217486461860465\ \(0\)\
\-\ echo\\:\\ 0\\.021411165393136797\ \(0\)\
\-\ hyperdense\\:\\ 0\\.021282494568417333\ \(0\)\
\-\ frequent\\:\\ 0\\.021198928915954495\ \(0\)\
\-\ higher\\:\\ 0\\.02099725593992228\ \(0\)\
\-\ enhance\\:\\ 0\\.02069410228990484\ \(0\)\
\-\ involve\\:\\ 0\\.020344507181164186\ \(0\)\
\-\ main\\:\\ 0\\.02014836613737834\ \(0\)\
\-\ that\\:\\ 0\\.020065203850921563\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.02005374416104557\ \(0\)\
\-\ developmental\\:\\ 0\\.019991868294167967\ \(0\)\
\-\ regions\\:\\ 0\\.0198411895809192\ \(0\)\
\-\ lobes\\:\\ 0\\.019288936563978693\ \(0\)\
\-\ resulting\\:\\ 0\\.019237634732672156\ \(0\)\
\-\ infarct\\:\\ 0\\.019237634732672156\ \(0\)\
\-\ clinically\\:\\ 0\\.019212225304255974\ \(0\)\
\-\ difficult\\:\\ 0\\.019186974191063032\ \(0\)\
\-\ development\\:\\ 0\\.01911215131712743\ \(0\)\
\-\ frequently\\:\\ 0\\.01903868482403155\ \(0\)\
\-\ cerebellar\\:\\ 0\\.0189191248099458\ \(0\)\
\-\ seizures\\:\\ 0\\.01887227121809008\ \(0\)\
\-\ dilatation\\:\\ 0\\.01887227121809008\ \(0\)\
\-\ bp\\:\\ 0\\.018757453608366448\ \(0\)\
\-\ be\\:\\ 0\\.018756577050642518\ \(0\)\
\-\ involved\\:\\ 0\\.01853713901298886\ \(0\)\
\-\ arm\\:\\ 0\\.018452260715799803\ \(0\)\
\-\ limited\\:\\ 0\\.018452260715799803\ \(0\)\
\-\ references\\:\\ 0\\.018431316015143938\ \(0\)\
\-\ nodular\\:\\ 0\\.01841047899979999\ \(0\)\
\-\ stage\\:\\ 0\\.01841047899979999\ \(0\)\
\-\ administration\\:\\ 0\\.01841047899979999\ \(0\)\
\-\ recommended\\:\\ 0\\.01838974856812071\ \(0\)\
\-\ excision\\:\\ 0\\.018227615325777387\ \(0\)\
\-\ fossa\\:\\ 0\\.018148917890784932\ \(0\)\
\-\ presenting\\:\\ 0\\.018110134910073086\ \(0\)\
\-\ hand\\:\\ 0\\.018071719546083952\ \(0\)\
\-\ slightly\\:\\ 0\\.018033664895063486\ \(0\)\
\-\ considered\\:\\ 0\\.018014770732372655\ \(0\)\
\-\ results\\:\\ 0\\.018014770732372655\ \(0\)\
\-\ includes\\:\\ 0\\.017977244625777496\ \(0\)\
\-\ partial\\:\\ 0\\.017812548758905675\ \(0\)\
\-\ temporal\\:\\ 0\\.01775910459247952\ \(0\)\
\-\ complications\\:\\ 0\\.017706356031501877\ \(0\)\
\-\ an\\:\\ 0\\.017680943921635786\ \(0\)\
\-\ history\\:\\ 0\\.017665280958088378\ \(0\)\
\-\ similar\\:\\ 0\\.017619939312754185\ \(0\)\
\-\ ct\\:\\ 0\\.017602930026686312\ \(0\)\
\-\ pressure\\:\\ 0\\.017602874906251866\ \(0\)\
\-\ used\\:\\ 0\\.017307399033995342\ \(0\)\
\-\ commonly\\:\\ 0\\.017106648369491502\ \(0\)\
\-\ its\\:\\ 0\\.017106648369491502\ \(0\)\
\-\ http\\:\\ 0\\.01709161016835303\ \(0\)\
\-\ course\\:\\ 0\\.01707662756143066\ \(0\)\
\-\ occur\\:\\ 0\\.017002534262754773\ \(0\)\
\-\ metastasis\\:\\ 0\\.01694421972348488\ \(0\)\
\-\ appears\\:\\ 0\\.016929771256999102\ \(0\)\
\-\ calcifications\\:\\ 0\\.016872487044557384\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.016732721795836607\ \(0\)\
\-\ dilated\\:\\ 0\\.016557947526808666\ \(0\)\
\-\ risk\\:\\ 0\\.016518663304298298\ \(0\)\
\-\ required\\:\\ 0\\.01650565272953936\ \(0\)\
\-\ defined\\:\\ 0\\.016492683788690815\ \(0\)\
\-\ intensity\\:\\ 0\\.016415729757252518\ \(0\)\
\-\ identified\\:\\ 0\\.016390399733817906\ \(0\)\
\-\ would\\:\\ 0\\.016365227040736167\ \(0\)\
\-\ headache\\:\\ 0\\.015936968398093058\ \(0\)\
\-\ underwent\\:\\ 0\\.015925694981764823\ \(0\)\
\-\ this\\:\\ 0\\.015887929055251458\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01578192471628592\ \(0\)\
\-\ left\\:\\ 0\\.015772511865144497\ \(0\)\
\-\ masses\\:\\ 0\\.015738694540457687\ \(0\)\
\-\ areas\\:\\ 0\\.01569592062829898\ \(0\)\
\-\ followed\\:\\ 0\\.015611703768225396\ \(0\)\
\-\ first\\:\\ 0\\.01560129865196621\ \(0\)\
\-\ week\\:\\ 0\\.015549670048592834\ \(0\)\
\-\ cases\\:\\ 0\\.015549670048592834\ \(0\)\
\-\ showed\\:\\ 0\\.015398616891720498\ \(0\)\
\-\ radiation\\:\\ 0\\.015320299661292964\ \(0\)\
\-\ injury\\:\\ 0\\.015075741594237274\ \(0\)\
\-\ no\\:\\ 0\\.015035806087505755\ \(0\)\
\-\ differential\\:\\ 0\\.015021340904191674\ \(0\)\
\-\ adjacent\\:\\ 0\\.014985475266965961\ \(0\)\
\-\ area\\:\\ 0\\.01497655823244069\ \(0\)\
\-\ aspect\\:\\ 0\\.01491468236556309\ \(0\)\
\-\ clinical\\:\\ 0\\.014651476788861934\ \(0\)\
\-\ demonstrated\\:\\ 0\\.014208064604599686\ \(0\)\
\-\ for\\:\\ 0\\.014014135587787725\ \(0\)\
\-\ region\\:\\ 0\\.013828496777619112\ \(0\)\
\-\ through\\:\\ 0\\.013761946997279118\ \(0\)\
\-\ all\\:\\ 0\\.013761946997279118\ \(0\)\
\-\ two\\:\\ 0\\.013729077469525472\ \(0\)\
\-\ presented\\:\\ 0\\.013481453349963722\ \(0\)\
\-\ significant\\:\\ 0\\.01334816571378225\ \(0\)\
\-\ than\\:\\ 0\\.013105272489255526\ \(0\)\
\-\ patients\\:\\ 0\\.013005472330075922\ \(0\)\
\-\ man\\:\\ 0\\.01223926962436987\ \(0\)\
\-\ without\\:\\ 0\\.012194188063238109\ \(0\)\
\-\ imaging\\:\\ 0\\.012149602458932972\ \(0\)\
\-\ posterior\\:\\ 0\\.01195482330448054\ \(0\)\
\-\ present\\:\\ 0\\.011862900402826882\ \(0\)\
\-\ have\\:\\ 0\\.011549004772843237\ \(0\)\
\-\ up\\:\\ 0\\.011435896299911106\ \(0\)\
\-\ findings\\:\\ 0\\.01140995242174281\ \(0\)\
\-\ surgical\\:\\ 0\\.01123638981923881\ \(0\)\
\-\ contrast\\:\\ 0\\.011232851808925264\ \(0\)\
\-\ after\\:\\ 0\\.011215207938843216\ \(0\)\
\-\ presents\\:\\ 0\\.011121236064594227\ \(0\)\
\-\ seen\\:\\ 0\\.010884045905899463\ \(0\)\
\-\ there\\:\\ 0\\.00919881599119056\ \(0\)\
\-\ not\\:\\ 0\\.009126670170365558\ \(0\)\
\-\ at\\:\\ 0\\.008732184855251037\ \(0\)\
\-\ right\\:\\ 0\\.007664769784308619\ \(0\)\
\-\ patient\\:\\ 0\\.007519317383518333\ \(0\)\
